Biobot Analytics

OverviewSuggest Edit

Biobot Analytics is a company that develops technology for wastewater analysis. It offers a system to measure opioids and other drug metabolites in sewage to estimate consumption in cities. The system can also measure infectious disease outbreaks, antibiotic resistance, nutrition, and exposure to environmental contaminants in populations.
TypePrivate
Founded2017
Websitebiobot.io

Latest Updates

Employees (est.) (Jul 2021)35(+10%)
Cybersecurity ratingAMore

Key People/Management at Biobot Analytics

Mariana Matus

Mariana Matus

CEO & Co-Founder
Newsha Ghaeli

Newsha Ghaeli

President & Co-Founder
Phil Kowalski

Phil Kowalski

Director of Customer Success
Show more

Biobot Analytics Financials and Metrics

Summary Metrics

Founding Date

2017

Biobot Analytics total Funding

$6.7 m

Biobot Analytics latest funding size

$4.2 m

Time since last funding

a year ago

Biobot Analytics investors

Biobot Analytics's latest funding round in April 2020 was reported to be $4.2 m. In total, Biobot Analytics has raised $6.7 m
Show all financial metrics

Biobot Analytics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Biobot Analytics Online and Social Media Presence

Embed Graph

Biobot Analytics Frequently Asked Questions

  • When was Biobot Analytics founded?

    Biobot Analytics was founded in 2017.

  • Who are Biobot Analytics key executives?

    Biobot Analytics's key executives are Mariana Matus, Newsha Ghaeli and Phil Kowalski.

  • How many employees does Biobot Analytics have?

    Biobot Analytics has 35 employees.

  • Who are Biobot Analytics competitors?

    Competitors of Biobot Analytics include SCA Pharma, Equipos Medicos Zepeda and EGF Theramed Health.